The 10 most innovative medical devices of 2018

The nominees for the best medical technology of 2018 were recently announced for the 12th Annual Prix Galien USA Awards. The host of the awards, The Galien Foundation, awards the Prix Galien Award annually to examples of outstanding biomedical and technology product achievements that are designed to improve human condition. Before the candidates can qualify

Pages: 1 2 3 4 5 6 7 8 9 10 11

The future of Abbott’s electrophysiology business

At DeviceTalks Minnesota 2018, medtech veteran Michael Pederson provided an inside look at the Abbott-St. Jude Medical merger and what’s ahead for Abbott’s cardiovascular technologies. Pederson tracked his career from a formative stint at HP to his current role as SVP of cardiac arrhythmias and heart failure at Abbott (NYSE:ABT). Get the full story at our sister

Big medical device companies are able to innovate, too: Here’s how

Startups and smaller firms outnumber the big medtech companies, but they haven’t cornered the market on research and development. The major players are always working on new devices and use their scale to quickly assemble teams to develop them. R&D executives from Abbott and Boston Scientific explained how their processes work and dispelled some myths

Abbott is developing a dual-chamber leadless pacemaker

Even before its acquisition by Abbott, St. Jude Medical had begun developing a dual-chamber leadless pacemaker, which would be a first if it succeeds. Abbott and Medtronic are the only companies that have developed single-chamber leadless pacemakers; St. Jude recalled its version, Nanostim, in October 2017 after receiving 7 reports of lost telemetry and pacing

8 companies commercializing transcatheter mitral valve replacements

Transcatheter mitral valve replacement is a new frontier in the cardio device field, with big legacy medical device companies including Edwards Lifesciences, Medtronic and Abbott spending hundreds of millions of dollars on companies in the space. Much different from transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR) has been mostly experimental. TMVR is used

Pages: 1 2 3 4 5 6 7 8 9

Minnesota’s Medical Alley has a big presence at EuroPCR

The Medical Alley Association in Minnesota is touting the major presence that companies and organizations from the state will have at this year’s EuroPCR, which is being held this week in Paris. The event — the European Association of Percutaneous Cardiovascular Interventions’ annual meeting — is May 22–25 at the Palais des Congrès and is expected to

Can Minnesota become a healthcare innovation hub?

Minnesota has the institutions and the talent to transform healthcare in the U.S. The question is whether the money will follow. RxFunction makes wearable devices called “Walkasins” that help people with chronic health conditions prevent falls that can lead to serious injury. It took eight painstaking years, though, before the Eden Prairie, Minn.-based startup secured

Stryker, J&J and Abbott ranked as top companies to work at in the U.S.

Stryker, Johnson & Johnson and Abbott have been named as some of LinkedIn’s top companies to work at in 2018. This marks the third year of “LinkedIn’s Top Companies 2018: Where the U.S. wants to work now,” which names the companies that professionals most want to work at based on a set of data points collected

Speakers you need to see at DeviceTalks Minnesota

A Google executive whose own heart problems spurred her to seek medtech innovation, a leader at Abbott who wants to drive healthcare value, the head of an upstart company seeking to transform diabetes care — those are but some of the speakers you will encounter at DeviceTalks Minnesota this June. Read on to find out

Pages: 1 2 3 4 5 6 7 8

For this Abbott executive, solving problems isn’t enough: ‘We need to add value’

As payers and providers across healthcare shift their focus to value-based care, leaders in the medical device industry are racing to keep up. Michael Pederson, SVP of cardiac arrhythmias and heart failure at Abbott, told MassDevice.com why simply solving problems with new technology isn’t enough anymore. What was your path like from electrical engineering to

Medtech stories we missed this week: April 27, 2018

From DuPuy Synthes’s spinal implant launch to Lumendi’s FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. DePuy Synthes launches spinal implants DePuy Synthes announced in an April 26 press release that it has launched its Proti 360º integrated titanium family of interbody devices that are designed

Bigfoot brings Series B total to $55m with new investment from Abbott

Reeling in an $18 million add-on to the $37 million Series B that it reported last year, Bigfoot Biomedical touted today that it has raised over $90 million in total funding since the Milpitas, Calif.-based company first launched. Investments from Abbott (NYSE:ABT), which has an established partnership with Bigfoot, and other new and existing investors, brought the […]

This medtech CEO led his company to a $200 million buyout

Guiding a company through a merger or an acquisition can test a CEO’s leadership skills. Here’s how NinePoint Medical CEO, Christopher von Jako, led his former medtech company, NeuroTherm, through a deal with St. Jude Medical. When Christopher von Jako assumed the corner office at NeuroTherm in 2013, the company had gone through two other

Hacking pacemakers is good TV, but is it for real?

Worry less about bad people hacking pacemakers and other cardiac devices. Worry more about them disrupting hospitals’ communications networks. That’s the major message out of the American College of Cardiology’s Electrophysiology Council, which published an article about cardiac devices earlier this month in the Journal of the American College of Cardiology.  The idea that hackers might

Webinar: The top medtech stories of 2017

This webinar was presented live on Tuesday, January 30, 2018. Click below to watch on demand.     The medtech industry saw its transformation accelerate in 2017: Whether it’s the roster of largest companies, business models or the regulatory environment, times are a-changing. Competition is also heating up in areas including diabetes care and robotic